NEW
Stock Screener with Intrinsic Value
Summit Therapeutics Inc. (SMMT)
Last Price$19.04.6%
Market Cap$13.8B
N/A
Peers median - 17.2%
48,028.4%
Peers median - 12.6%
7.4%
Peers median - 10.1%
(2,476.8%)
Peers median - (16.7%)
Competing with SMMT
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare SMMT Valuation Multiples with Peers
Crunching data... Almost there!
Compare SMMT Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Summit Therapeutics Inc. (SMMT) revenue growth compare to peers and the industry?
Summit Therapeutics Inc. (SMMT) revenue growth is N/A, compared to the peers' median of 17.2%.
2. How does Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) margin compare to peers and the industry?
Summit Therapeutics Inc. (SMMT) FCF margin is 48,028.4%, compared to the peers' median of 12.6%.
3. How does Summit Therapeutics Inc. (SMMT) Total Debt to Equity ratio compare to peers and the industry?
Summit Therapeutics Inc. (SMMT) Total Debt to Equity ratio is 7.4%, compared to the peers' median of 10.1%.
4. How does Summit Therapeutics Inc. (SMMT) ROIC (Return on Invested Capital) compare to peers and the industry?
Summit Therapeutics Inc. (SMMT) ROIC is (2,476.8%), compared to the peers' median of (16.7%).